PeptideCompareVilon — EU research guide.
Vilon (Lys-Glu) is a synthetic dipeptide bioregulator from the Khavinson series targeting immune system tissue. It is studied for immune senescence reversal and longevity in Russian gerontological research.
What is Vilon?
Vilon is one of the shortest bioregulator peptides — a simple dipeptide of lysine and glutamic acid. Despite its small size, it is proposed to penetrate cells and modulate gene expression in immune tissue, particularly T-cell populations. It was developed alongside Epithalon and Thymalin in the same Russian research programme.
What does the research show?
Russian studies report immune restoration effects in aged animals, including increased T-helper and NK-cell activity, and improved thymic function. A long-term Russian human study reported reduced morbidity and enhanced immune markers in elderly subjects over multi-year follow-up. No Western independent replication exists.
EU legal status
Not approved in the EU as a medicine. Available from specialist research vendors as a laboratory compound for immunology research.
Molecular information
Pharmacokinetics
Potency retained over time
Each line is one storage condition: it starts at 100% and falls as potency is lost. Above the dashed 80% line the material is considered reliable — hover for exact values.
⚠ Estimates modelled per compound from its molecular properties (sequence length, cyclisation, oxidation- and deamidation-prone residues, light sensitivity). Indicative only — not lab-measured per batch.
Vilon across EU suppliers
COA-verified EU vendors · Updated monthly